The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Actionable targets in patients with cisplatin-resistant advanced germ cell tumors.
 
Aditya Bagrodia
No Relationships to Disclose
 
Samuel D. Kaffenberger
No Relationships to Disclose
 
Byron Lee
No Relationships to Disclose
 
William Lee
No Relationships to Disclose
 
Eugene K. Cha
No Relationships to Disclose
 
John Sfakianos
No Relationships to Disclose
 
Sizhi Paul Gao
No Relationships to Disclose
 
Emily Craig Zabor
No Relationships to Disclose
 
Irina Ostrovnaya
No Relationships to Disclose
 
Jana Eng
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics
 
Dean F. Bajorin
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Genentech; Merck; Novartis; Roche; Roche/Genentech
Research Funding - Amgen (Inst); dendreon (Inst); Genentech/Roche (Inst); Merck; Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Roche/Genentech
 
Nikolaus Schultz
No Relationships to Disclose
 
Joel Sheinfeld
No Relationships to Disclose
 
George J. Bosl
No Relationships to Disclose
 
Hikmat Al-Ahmadie
No Relationships to Disclose
 
David B. Solit
Honoraria - Loxo; Novartis; Pfizer
Consulting or Advisory Role - Loxo; Novartis; Pfizer
 
Darren R. Feldman
Consulting or Advisory Role - Bayer; Gilead Sciences (I); Seagen
Research Funding - Novartis